HIGHLIGHTS from SABCS: Addition of S-1 to Post-operative Endocrine Therapy Improves Outcomes for Patients with Hormone Receptor-positive, HER2-negative Breast Cancer

HIGHLIGHTS from SABCS: New HER2 Antibody-drug Conjugate Yielded Promising Clinical Responses in Breast Cancer Patients Pre-treated with T-DM1

HIGHLIGHTS from SABCS: Phase III SOPHIA study: HER2+metastatic breast cancer interim overall survival analysis

HIGHLIGHTS from SABCS: Assessing immune biomarkers of response to anthracyclines in breast cancer

HIGHLIGHTS from SABCS: The Genomic Landscape of Male Breast Cancers using the Oncomine Comprehensive Assay for Actionable Mutations.